Skip to main content
Công ty Cổ phần Dược Hậu Giang logo

Công ty Cổ phần Dược Hậu Giang — Investor Relations & Filings

Ticker · DHG ISIN · VN000000DHG0 HSX Manufacturing
Open in API
Filings indexed 182 across all filing types
Latest filing 2025-07-30 Governance Information
Country VN Viet Nam
Listing HSX DHG

About Công ty Cổ phần Dược Hậu Giang

www.dhgpharma.com.vn

Công ty Cổ phần Dược Hậu Giang (DHG Pharma) is a leading pharmaceutical enterprise with over 50 years of experience. The company specializes in the research, development, manufacturing, and distribution of a diverse portfolio of pharmaceutical products, including both supportive and treatment medications. DHG Pharma emphasizes the application of high technology and international production standards to ensure product quality. Key brands include Telfor, Bocalex, Natto DHA, Hapacol, and Biofermin, serving a broad consumer base. Committed to public health, DHG Pharma actively engages in community health initiatives and strives to provide high-quality, accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
DHG: Báo cáo tình hình quản trị 6 tháng đầu năm 2025
Governance Information Classification · 95% confidence The document is titled “Báo cáo tình hình quản trị” (Governance Report) for the first half of 2025. It provides detailed information on the company’s governance structure—AGM resolutions, board composition and meetings, audit committee activities, executive appointments, internal control oversight, related-party listings, and insider transactions. It does not contain full financial statements (so it’s not an interim report) nor is it a simple publication notice or proxy statement. This aligns precisely with the Governance Information (CGR) category.
2025-07-30 Vietnamese
DHG: Giải trình biến động KQKD quý 2/2025 so với cùng kỳ năm trước
Earnings Release Classification · 86% confidence The document is a short, standalone disclosure of the company’s second‐quarter and half‐year 2025 business results, including key financial metrics (net sales, profit before tax, profit after tax) and year‐over‐year growth commentary. It does not contain full financial statements or attach a full interim report; rather, it provides summary highlights. This aligns with an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results. Q2 2025
2025-07-21 Vietnamese
DHG: Thông báo về việc đã ký hợp đồng dịch vụ kiểm toán độc lập 2025
Regulatory Filings Classification · 85% confidence The document is an extraordinary information disclosure to the State Securities Commission and the Ho Chi Minh Stock Exchange announcing the signing of an independent audit service contract for interim review (6 months) and the year-end audit. It does not contain actual audited financial statements or substantive financial data, nor is it the audit report itself. It is an announcement of a corporate disclosure and therefore falls under general regulatory filings. Consequently, it should be classified as Regulatory Filings (RNS).
2025-06-30 Vietnamese
DHG: Thông báo về ngày đăng ký cuối cùng chi trả cổ tức năm 2024 bằng tiền
Notice of Dividend Amount Classification · 95% confidence The document is an official notice from the Ho Chi Minh City Stock Exchange specifying the ex-dividend date, record date, dividend rate, payment date, and procedures for receiving the 2024 cash dividend of Công ty Cổ phần Dược Hậu Giang. This exactly matches the definition of a Notice of Dividend Amount (Code: DIV).
2025-05-16 Vietnamese
DHG: Thông báo về ngày đăng ký cuối cùng chốt danh sách chi trả cổ tức năm 2024
Notice of Dividend Amount Classification · 96% confidence The document is an extraordinary information disclosure announcing the dividend payment for 2024, including the record date, payment date, and dividend rate per share. This fits the “Notice of Dividend Amount” category.
2025-05-12 Vietnamese
DHG: Nghị quyết và Biên bản họp ĐHĐCĐ thường niên năm 2025
AGM Information Classification · 85% confidence The document is the formal resolution and minutes (Nghị quyết and Biên bản) of the 2024 Annual General Meeting of Shareholders for DHG Pharmaceutical JSC, detailing agenda items, voting results, approvals of financial statements, dividend distributions, board changes, auditor appointment, and election results. This is not a mere announcement of a report but the actual meeting outcomes and materials from the AGM, matching the definition of AGM Information (AGM-R).
2025-04-25 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.